2,3-dinor-thromboxane b2 has been researched along with bradykinin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fitzgerald, DJ; Keimowitz, RM; Mayo, G; Pulvermacher, G | 1 |
Dechaux, E; Dowell, FJ; Henrion, D; Lévy, BI; Maclour, J; Michel, JB; Samuel, JL | 1 |
2 other study(ies) available for 2,3-dinor-thromboxane b2 and bradykinin
Article | Year |
---|---|
Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
Topics: Administration, Cutaneous; Adult; Aspirin; Blood Platelets; Bradykinin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Male; Middle Aged; Salicylates; Salicylic Acid; Thromboxane B2 | 1993 |
Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase 1; Cyclooxygenase 2; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Isoenzymes; Isoquinolines; Male; Membrane Proteins; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; Prostaglandin-Endoperoxide Synthases; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Thromboxane B2; Vascular Resistance; Vasodilation | 1997 |